About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2012 (2012), Article ID 421709, 8 pages
http://dx.doi.org/10.1155/2012/421709
Review Article

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA

1Department of Urologic Surgery, Vanderbilt University, Nashville, TN 37203, USA
2Allergan Inc., P.O. Box 19534, Irvine, CA 92623, USA
3Xcenda, 4114 Woodlands Parkway Suite 500, Palm Harbor, FL 34685, USA

Received 2 December 2011; Accepted 22 February 2012

Academic Editor: Peter E. Clark

Copyright © 2012 Daniel A. Barocas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Anna V van Lingen, and J Alfred Witjes, “Current intravesical therapy for non-muscle invasive bladder cancer,” Expert Opinion on Biological Therapy, pp. 1–15, 2013. View at Publisher · View at Google Scholar
  • Darryl T. Martin, Christopher J. Hoimes, Hristos Z. Kaimakliotis, Christopher J. Cheng, Ke Zhang, Jingchun Liu, Marcia A. Wheeler, W. Kevin Kelly, Greg N. Tew, W. Mark Saltzman, and Robert M. Weiss, “Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer,” Nanomedicine: Nanotechnology, Biology and Medicine, 2013. View at Publisher · View at Google Scholar
  • Helena Furberg, and Bernard H. Bochner, “Bladder cancer: Towards risk stratification in bladder cancer,” Nature Reviews Urology, 2013. View at Publisher · View at Google Scholar
  • Singer, Ziegler, Schwalenberg, Hinz, Götze, and Schulte, “Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer,” Supportive Care in Cancer, vol. 21, no. 5, pp. 1383–1393, 2013. View at Publisher · View at Google Scholar
  • Joseph Cusano, Peter Haddock, Max Jackson, Matthew Luk, Scott Wiener, Ashley Cox, and Anoop Meraney, “Process Improvements Positively Impact the Use of Intravesical Mitomycin C after Transurethral Resection of Nonmuscle Invasive Bladder Cancer in a Large, Urban Urology Practice,” Urology Practice, 2015. View at Publisher · View at Google Scholar
  • Sonia Domingos-Pereira, Rim Hojeij, Erica Reggi, Laurent Derré, Mathieu F. Chevalier, Pedro Romero, Patrice Jichlinski, and Denise Nardelli-Haefliger, “ Local Salmonella immunostimulation recruits vaccine-specific CD8 T-cells and increases bladder-tumor regression ,” OncoImmunology, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • Ben Tomlinson, Tzu-yin Lin, Marc Dall'Era, and Chong-Xian Pan, “Nanotechnology in bladder cancer: current state of development and clinical practice,” Nanomedicine, vol. 10, no. 7, pp. 1189–1201, 2015. View at Publisher · View at Google Scholar
  • Dalia Mohamed, Ibrahim Elsayed, Aly Fahmy Mohamed, and Soad Ali Yehia, “Real time stability and viability prediction of the anticancer BCG after lyophilization,” Drug Development and Industrial Pharmacy, pp. 1–8, 2015. View at Publisher · View at Google Scholar